<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03230799</url>
  </required_header>
  <id_info>
    <org_study_id>CCPMOH2017-China-3</org_study_id>
    <nct_id>NCT03230799</nct_id>
  </id_info>
  <brief_title>Comparison of Minimal Invasive Lens Surgery and Traditional Cataract Surgery</brief_title>
  <official_title>Comparison of Minimal Invasive Lens Surgery and Traditional Cataract Surgery for Treating Congenital Cataracts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Previously, we have developed a minimal invasive lens surgery in the purpose of reduce
      post-operative complications of congenital cataract. This prospective, randomized controlled
      study aims at comparing the prognosis of the minimal invasive lens surgery and the
      traditional cataract surgery for treating congenital cataracts.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with congenital cataract that requires surgical intervention are enrolled. Then the
      patients are assigned to two groups: Group I: the participants receive a minimal invasive
      lens surgery, while in Group II, the participants receive a traditional cataract surgery. A
      secondary intraocular lens implantation is performed when the patient is two years old for
      both Group I and Group II. Investigators then compare the visual acuity, incidence of high
      intraocular pressure, incidence of visual axis opacification, uveitis and iris/pupil
      abnormality between two groups, to evaluate and compare the prognosis of minimal invasive
      lens surgery and traditional cataract surgery for treating congenital cataracts.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 28, 2017</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Best correctied visual acuity</measure>
    <time_frame>recorded at each follow-up to five years of age.</time_frame>
    <description>Determined with the Teller's acuity card, the Lea symbol visual acuity chart or the ETDRS chart according the patient's age.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>High intra-ocular pressure</measure>
    <time_frame>after lens removal to five years of age.</time_frame>
    <description>Determined with Tono-Pen tonometer at each follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual axis opacification</measure>
    <time_frame>after lens removal to five years of age.</time_frame>
    <description>Determined with slit-lamp photography at each follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bi-ocular visual function</measure>
    <time_frame>performed when the patient is four years old and five years old.</time_frame>
    <description>Determined with synoptophore</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Congenital Cataract</condition>
  <arm_group>
    <arm_group_label>traditional cataract surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>minimal invasive lens surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>minimal invasive lens surgery</intervention_name>
    <description>We decreased the size of the capsulorhexis opening to 1.0-1.5 mm in diameter. Then we moved the location of the capsulorhexis to the peripheral area of the lens instead of the central area. A 0.9 mm phacoemulsification probe was used to remove the lens contents and/or cortical opacities.</description>
    <arm_group_label>minimal invasive lens surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>traditional cataract surgery</intervention_name>
    <description>ACCC+ I/A + PCCC + Anti-vit: anterior continuous capsulorhexis + irrigation/aspiration + posterior capsulorhexis + anterior vitrectomy</description>
    <arm_group_label>traditional cataract surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 1 month and 24 months

          -  Uncomplicated congenital cataract (â‰¥ 3 mm central dense opacity) in one or both eyes
             with an intact non-fibrotic capsular bag

          -  Informed consent signed by a parent or legal guardian

        Exclusion Criteria:

          -  confirmed or suspected hereditary cataract, including and not restricted to family
             history of congenital cataract

          -  Intraocular pressure &gt;21 mmHg

          -  Preterm birth (&lt;28 weeks)

          -  Presence of other ocular diseases (keratitis, keratoleukoma, aniridia, glaucoma) or
             systemic disease (congenital heart disease, ischemic encephalopathy)

          -  History of ocular diseases (any congenital eye diseases, such as, congenital cataract,
             congenital glaucoma, congenital aniridia) in the family

          -  History of ocular trauma

          -  Microcornea

          -  Persistent hyperplastic primary vitreous

          -  Rubella

          -  Lowe syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>24 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yizhi Liu, M.D,Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jing Li, M.D</last_name>
    <phone>+86-20-87330341</phone>
    <email>Reviewborad_SYsU@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center,Sun Yat-sen U</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510060</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haotian Lin, Phd</last_name>
      <phone>+86-20-87330475</phone>
      <email>gddlht@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Haotian Lin, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yizhi Liu, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>July 17, 2017</study_first_submitted>
  <study_first_submitted_qc>July 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2017</study_first_posted>
  <last_update_submitted>November 7, 2018</last_update_submitted>
  <last_update_submitted_qc>November 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Haotian Lin</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>congenital cataract</keyword>
  <keyword>minimal invasive surgery</keyword>
  <keyword>secondary intraocular lens implantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

